Revelation Biosciences Inc (FRA:56U0)
€ 8.88 0 (0%) Market Cap: 3.05 Mil Enterprise Value: 8.79 Mil PE Ratio: 0 PB Ratio: 0.32 GF Score: 24/100

Petra Acquisition Inc and Revelation Biosciences Inc. Merger Call Transcript

Aug 30, 2021 / 08:30PM GMT
Operator

Greetings and welcome to Petra Acquisition, Inc. and Revelation Biosciences, Inc. merger call. (Operator instructions). As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Andreas Typaldos, CEO of Petra Acquisition, Inc.

Andreas Typaldos
Petra Acquisition, Inc. - CEO

Thank you. Thank you, everybody, for taking time to learn about Petra's merger with Revelation Biosciences. I'm excited to present this opportunity after looking at many companies that Petra could merge with. I think you will share our excitement about Revelation.

First, because of the potential impact on health outcomes in key disease categories, for a large segment of healthcare, for people with viral respiratory diseases, and COVID-19. And as a result of that, we are excited about the potential upside for our shareholders. I think you will agree about our excitement stemming from three key values and considerations.

As always, first and foremost is the Revelation team, whom I will introduce shortly. Three NASDAQ and one

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot